Let's look at the major provisions that will have lasting effect on the industry, both domestic and exports.
The United States agreed with the nascent pharmaceutical industry in India that adequate protection of intellectual property rights would boost its ability to attract financing and safeguard new inventions, a senior State Department official said.
The United States, he said, 'desires a new age of ambition' in its relationship with India. Asserting that the US has never been more supportive of India's security, he said New Delhi too, is an important partner and a key pillar of President Trump's foreign policy.
Cancun appears headed for a fiasco like Seattle with Tokyo World Trade Organisation mini-ministerial hitting roadblocks.
India could lose over $130 billion annually, if western countries were allowed to exploit and dilute ayurveda, one of the trusted age-old Indian medicine system, experts say.
On the Sensex chart, Bajaj Auto, HDFC, Infosys, Tech Mahindra and ICICI bank emerged as the prominent gainers. NSE Nifty ended with a gain of 106.95 points at 14,724.80.
Come year 2005, a catastrophe is set to hit developing nations including India, experts warn, as the TRIPs agreement tightens its noose on the pharmaceutical sector and the governments retire to the role of an onlooker at the rising prices of drugs.
Google received 26,087 complaints from users and removed 61,114 pieces of content based on those complaints in November, the tech giant said in its monthly transparency report.
Pompeo describes Swaraj somewhat disparagingly, using the American slang words "goofball" and "heartland political hack" for her.
China has consistently spent more than 2% of GDP on R&D while India's expenditure on R&D has stagnated around 0.7% of GDP. Can our government shore up resources so that we hit the R&D expenditure target of 2% of GDP set out by the Science, Technology and Innovation Policy of 2013, asks Chidambaran G Iyer, Senior Fellow, Pahle India Foundation.
Federation of Indian Chambers of Commerce and Industry on Wednesday asked the US to restore the Generalised System of Preferences for Indian exports of chemicals and allied products.\n\n\n\n
Domestic pharma giant Ranbaxy Laboratories Limited has topped the list of patent filers in the area of drug applications from the Third World countries last year with 64 new formulations.\n\n\n\n
In addition to reports from users, Google also removed 3,84,509 pieces of content in October as a result of automated detection.
The jailed gangster had on Thursday moved the court against the web series, saying that the 'use or misuse of the attributes of his personality' without his prior consent amounted to infringement of his 'personality rights' as well as defamation.
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.
Close on the heels of Boeing's defence of India to the US International Trade Commission's investigation into India's trade, investment and industrial policies, IBM has also sprung to New Delhi's defence in an otherwise sea of criticism of India's violations of intellectual property rights, local content requirements, among other issues of concern to US business and industry.
Seven months down the line, not much progress has been made, except that the scheme is still being fine-tuned.
Mumbai-based L&T Infotech, a part of the Larsen &Toubro group, is evaluating acquisitions of $50-200 million (close to Rs 200-820 crore) in the US, Europe and India in a bid to boost revenues.
Senior officials of India and the US will meet after the forthcoming Budget session to identify and prioritise sectors for investments and technology sharing.
A Priority Foreign Country is a status reserved for those nations that are the most egregious violators of intellectual property rights and have the most negative impact on US competitiveness abroad.
From Lalit K Jha Washington, May 15 (PTI) Alleging that recent trade policies of India are jeopardising its trade ties with the US, a Washington-based think tank has recommended the Congress to suspend trade benefits for New Delhi. "To be clear, a strong, growing, and collaborative trade relationshi ...
Delegation visit ahead of patent law report.
China has been an aggressor against India along the Himalayan border, a top American diplomat nominated by President Joe Biden as his next envoy to Beijing has told lawmakers, stating that the US must hold the Chinese government accountable for failing to play by the rules.
The Railway Board and employees at Integral Coach Factory in Chennai, makers of the train, are at loggerheads over the proposed transfer of design and reassigning the manufacturing of Train 18 to Modern Coach Factory in Raebareli.
In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.
Special 301 Report expresses concern over weak IPR laws, to conduct reviews.
In a country like India, where counterfeit items are sold in every nook and corner, the regulation of trademark infringement poses a big challenge.
India and US keen to strengthen trade ties, hold talks after 4 years.
The company employs 4,200 people across three centres in Noida and Bengaluru, which together employ a fourth of its global workforce
'India's specific concerns about whether Russia will be a reliable defense supplier and diplomatic partner in the event of heightened hostilities with China has undoubtedly accelerated the process of US-India defense and intelligence cooperation intended to support Indian military positions along the Line of Actual Control.'
Batting great Matthew Hayden is ready to help Australia solve their batting woes in the ongoing four-Test series if asked.
